Imagion Biosystems Ltd. (AU:IBX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Imagion Biosystems Ltd. has secured $3 million in new funding through a share placement led by CPS Capital, which will accelerate the company’s MagSense technology clinical programs for cancer detection. Additionally, the company has entered into a licensing agreement with Biosensis to commercialize its PrecisionMRX nanoparticles, providing a new revenue stream through milestone fees and royalties. These strategic moves are expected to bolster Imagion’s market position and enhance its research and development efforts.
For further insights into AU:IBX stock, check out TipRanks’ Stock Analysis page.